Bharat Rasayan (590021) 주식 개요인도에서 기술 등급 농약과 중간체를 제조 및 판매하는 Bharat Rasayan Limited. 자세히 보기590021 펀더멘털 분석스노우플레이크 점수가치 평가2/6미래 성장0/6과거 실적1/6재무 건전성5/6배당0/6강점주가수익률(17.3x)이 Indian 시장(23.3x)보다 낮습니다.위험 분석지난 5년간 매년 수익이 4.7% 감소했습니다.이익 마진 (10.7%)이 지난해 (15.6%)보다 낮습니다.모든 위험 점검 보기590021 Community Fair Values Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.Your Fair Value₹Current Price₹1.39k75.2% 고평가 내재 할인율Growth estimate overAnnual revenue growth rate5 Yearstime period%/yrDecreaseIncreasePastFuture014b2016201920222025202620282031Revenue ₹13.0bEarnings ₹1.4bAdvancedSet Fair ValueView all narrativesBharat Rasayan Limited 경쟁사Insecticides (India)Symbol: BSE:532851Market cap: ₹21.0bIndia PesticidesSymbol: NSEI:IPLMarket cap: ₹19.0bGSP Crop ScienceSymbol: NSEI:GSPCROPMarket cap: ₹19.9bMeghmani OrganicsSymbol: NSEI:MOLMarket cap: ₹13.2b가격 이력 및 성과Bharat Rasayan 주가의 최고가, 최저가 및 변동 요약과거 주가현재 주가₹1,385.5052주 최고가₹3,030.2552주 최저가₹1,202.05베타0.161개월 변동-11.47%3개월 변동-17.03%1년 변동-42.11%3년 변동-44.22%5년 변동-55.33%IPO 이후 변동19,345.61%최근 뉴스 및 업데이트공시 • May 09Bharat Rasayan Limited to Report Q4, 2026 Results on May 26, 2026Bharat Rasayan Limited announced that they will report Q4, 2026 results on May 26, 2026Valuation Update With 7 Day Price Move • Apr 13Investor sentiment improves as stock rises 18%After last week's 18% share price gain to ₹1,573, the stock trades at a trailing P/E ratio of 19.7x. Average trailing P/E is 21x in the Chemicals industry in India. Total loss to shareholders of 34% over the past three years.Reported Earnings • Feb 14Third quarter 2026 earnings released: EPS: ₹24.08 (vs ₹24.39 in 3Q 2025)Third quarter 2026 results: EPS: ₹24.08 (down from ₹24.39 in 3Q 2025). Revenue: ₹2.80b (up 9.2% from 3Q 2025). Net income: ₹400.3m (down 1.2% from 3Q 2025). Profit margin: 14% (down from 16% in 3Q 2025). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 10% per year but the company’s share price has fallen by 9% per year, which means it is significantly lagging earnings.Valuation Update With 7 Day Price Move • Feb 03Investor sentiment improves as stock rises 16%After last week's 16% share price gain to ₹1,939, the stock trades at a trailing P/E ratio of 24.2x. Average trailing P/E is 22x in the Chemicals industry in India. Total loss to shareholders of 14% over the past three years.공시 • Jan 30Bharat Rasayan Limited to Report Q3, 2026 Results on Feb 12, 2026Bharat Rasayan Limited announced that they will report Q3, 2026 results on Feb 12, 2026New Risk • Jan 20New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 7.8% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 4.6% per year over the past 5 years. Minor Risk Share price has been volatile over the past 3 months (7.8% average weekly change).더 많은 업데이트 보기Recent updates공시 • May 09Bharat Rasayan Limited to Report Q4, 2026 Results on May 26, 2026Bharat Rasayan Limited announced that they will report Q4, 2026 results on May 26, 2026Valuation Update With 7 Day Price Move • Apr 13Investor sentiment improves as stock rises 18%After last week's 18% share price gain to ₹1,573, the stock trades at a trailing P/E ratio of 19.7x. Average trailing P/E is 21x in the Chemicals industry in India. Total loss to shareholders of 34% over the past three years.Reported Earnings • Feb 14Third quarter 2026 earnings released: EPS: ₹24.08 (vs ₹24.39 in 3Q 2025)Third quarter 2026 results: EPS: ₹24.08 (down from ₹24.39 in 3Q 2025). Revenue: ₹2.80b (up 9.2% from 3Q 2025). Net income: ₹400.3m (down 1.2% from 3Q 2025). Profit margin: 14% (down from 16% in 3Q 2025). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 10% per year but the company’s share price has fallen by 9% per year, which means it is significantly lagging earnings.Valuation Update With 7 Day Price Move • Feb 03Investor sentiment improves as stock rises 16%After last week's 16% share price gain to ₹1,939, the stock trades at a trailing P/E ratio of 24.2x. Average trailing P/E is 22x in the Chemicals industry in India. Total loss to shareholders of 14% over the past three years.공시 • Jan 30Bharat Rasayan Limited to Report Q3, 2026 Results on Feb 12, 2026Bharat Rasayan Limited announced that they will report Q3, 2026 results on Feb 12, 2026New Risk • Jan 20New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 7.8% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 4.6% per year over the past 5 years. Minor Risk Share price has been volatile over the past 3 months (7.8% average weekly change).공시 • Jan 20Bharat Rasayan Limited Announces Change in Designation of Rajender Prasad Gupta from Executive Director to Non-Executive, Non-Independent Director, Effective January 19, 2026Bharat Rasayan Limited announced that the Board of Directors of the Company, at its meeting held on January 19, 2026, has approved the letter dated January 19, 2026 received from Shri Rajender Prasad Gupta (DIN:00048888) regarding the change in his designation from Executive Director to Non-Executive, Non-Independent Director, with effect from January 19, 2026. The change in designation is due to other occupancies of Sh. Rajender Prasad Gupta, for which he step back from day-to-day executive responsibilities. He will continue to serve on the Board in a Non-Executive Director capacity.Valuation Update With 7 Day Price Move • Jan 20Investor sentiment deteriorates as stock falls 23%After last week's 23% share price decline to ₹1,684, the stock trades at a trailing P/E ratio of 21.1x. Average trailing P/E is 23x in the Chemicals industry in India. Total loss to shareholders of 29% over the past three years.Valuation Update With 7 Day Price Move • Oct 23Investor sentiment improves as stock rises 23%After last week's 23% share price gain to ₹11,640, the stock trades at a trailing P/E ratio of 35.1x. Average trailing P/E is 26x in the Chemicals industry in India. Total returns to shareholders of 3.4% over the past three years.Upcoming Dividend • Sep 05Upcoming dividend of ₹1.50 per shareEligible shareholders must have bought the stock before 12 September 2025. Payment date: 19 October 2025. Payout ratio is a comfortable 0.4% and this is well supported by cash flows. The company last paid an ordinary dividend in May 2015. The average dividend yield among industry peers is 0.7%.Declared Dividend • Aug 15Dividend of ₹1.50 announcedDividend of ₹1.50 is the same as last year. Ex-date: 12th September 2025 Payment date: 19th October 2025 Dividend yield will be 0.01%, which is lower than the industry average of 0.8%. Payout Ratios Payout ratio: 0.4423%. Cash payout ratio: 0.4572%.공시 • Aug 14Bharat Rasayan Limited announces Annual dividend, payable on October 19, 2025Bharat Rasayan Limited announced Annual dividend of INR 1.5000 per share payable on October 19, 2025, ex-date on September 12, 2025 and record date on September 12, 2025.Reported Earnings • Aug 14First quarter 2026 earnings released: EPS: ₹95.45 (vs ₹104 in 1Q 2025)First quarter 2026 results: EPS: ₹95.45 (down from ₹104 in 1Q 2025). Revenue: ₹3.77b (up 34% from 1Q 2025). Net income: ₹396.6m (down 8.0% from 1Q 2025). Profit margin: 11% (down from 15% in 1Q 2025). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has fallen by 1% per year whereas the company’s share price has fallen by 3% per year.공시 • Aug 13Bharat Rasayan Limited, Annual General Meeting, Sep 19, 2025Bharat Rasayan Limited, Annual General Meeting, Sep 19, 2025.Valuation Update With 7 Day Price Move • Jun 17Investor sentiment improves as stock rises 16%After last week's 16% share price gain to ₹10,419, the stock trades at a trailing P/E ratio of 30.7x. Average trailing P/E is 29x in the Chemicals industry in India. Total loss to shareholders of 1.8% over the past three years.Reported Earnings • May 29Full year 2025 earnings released: EPS: ₹678 (vs ₹230 in FY 2024)Full year 2025 results: EPS: ₹678 (up from ₹230 in FY 2024). Revenue: ₹24.0b (up 130% from FY 2024). Net income: ₹2.82b (up 195% from FY 2024). Profit margin: 12% (up from 9.1% in FY 2024). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 7% per year but the company’s share price has fallen by 10% per year, which means it is significantly lagging earnings.Reported Earnings • Feb 15Third quarter 2025 earnings released: EPS: ₹97.54 (vs ₹36.85 in 3Q 2024)Third quarter 2025 results: EPS: ₹97.54 (up from ₹36.85 in 3Q 2024). Revenue: ₹2.64b (up 13% from 3Q 2024). Net income: ₹405.3m (up 165% from 3Q 2024). Profit margin: 15% (up from 6.6% in 3Q 2024). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 9% per year whereas the company’s share price has fallen by 7% per year.공시 • Jan 21Bharat Rasayan Limited to Report Q3, 2025 Results on Feb 13, 2025Bharat Rasayan Limited announced that they will report Q3, 2025 results on Feb 13, 2025공시 • Oct 22Bharat Rasayan Limited to Report Q2, 2025 Results on Nov 12, 2024Bharat Rasayan Limited announced that they will report Q2, 2025 results on Nov 12, 2024Upcoming Dividend • Sep 05Upcoming dividend of ₹1.50 per shareEligible shareholders must have bought the stock before 12 September 2024. Payment date: 19 October 2024. Payout ratio is a comfortable 0.7% and this is well supported by cash flows. The company last paid an ordinary dividend in May 2014. The average dividend yield among industry peers is 0.6%.Declared Dividend • Aug 10Dividend of ₹1.50 announcedDividend of ₹1.50 is the same as last year. Ex-date: 12th September 2024 Payment date: 19th October 2024 Dividend yield will be 0.01%, which is lower than the industry average of 0.8%. Payout Ratios Payout ratio: 0.6526%. Cash payout ratio: 4%.공시 • Aug 09Bharat Rasayan Limited, Annual General Meeting, Sep 19, 2024Bharat Rasayan Limited, Annual General Meeting, Sep 19, 2024.New Risk • Aug 09New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Indian stocks, typically moving 10% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (10% average weekly change). Earnings have declined by 7.9% per year over the past 5 years.Reported Earnings • Aug 09First quarter 2025 earnings released: EPS: ₹104 (vs ₹17.06 in 1Q 2024)First quarter 2025 results: EPS: ₹104 (up from ₹17.06 in 1Q 2024). Revenue: ₹2.88b (up 20% from 1Q 2024). Net income: ₹431.2m (up ₹360.3m from 1Q 2024). Profit margin: 15% (up from 3.0% in 1Q 2024). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 21% per year but the company’s share price has only fallen by 1% per year, which means it has not declined as severely as earnings.공시 • Aug 09Bharat Rasayan Limited Announces Cessation of Smt. Sujata Agarwal as an Independent & Non Executive Woman Director, effective August 31, 2024Bharat Rasayan Limited informed that the existing tenure of Smt. Sujata Agarwal as an Independent & Non Executive Woman Director of the Company is going to be completed on August 31, 2024. Company further confirmed that there is no other material reason for his cessation other than those provided above.New Risk • Jun 13New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 8.5% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 6.6% per year over the past 5 years. Minor Risk Share price has been volatile over the past 3 months (8.5% average weekly change).Reported Earnings • Jun 04Full year 2024 earnings released: EPS: ₹230 (vs ₹300 in FY 2023)Full year 2024 results: EPS: ₹230 (down from ₹300 in FY 2023). Revenue: ₹10.7b (down 14% from FY 2023). Net income: ₹955.1m (down 23% from FY 2023). Profit margin: 9.0% (down from 10% in FY 2023). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has fallen by 24% per year but the company’s share price has only fallen by 9% per year, which means it has not declined as severely as earnings.공시 • May 31Bharat Rasayan Limited Recommends Final Dividend for the Financial Year Ended March 31, 2024The board of directors of Bharat Rasayan Limited at its meeting held on May 30, 2024, recommended a final dividend @15%, i.e. INR 1.50 per share on the fully paid-up equity shares on INR 10 each for the financial year ended March 31, 2024. However, the final dividend of INR 1.50 per share recommended would be payable after the approval of the said final dividend by the shareholders of the Company in their forthcoming Annual General Meeting.Valuation Update With 7 Day Price Move • May 31Investor sentiment improves as stock rises 15%After last week's 15% share price gain to ₹10,699, the stock trades at a trailing P/E ratio of 75.8x. Average trailing P/E is 29x in the Chemicals industry in India. Total loss to shareholders of 18% over the past three years.공시 • May 05Bharat Rasayan Limited to Report Q4, 2024 Results on May 30, 2024Bharat Rasayan Limited announced that they will report Q4, 2024 results on May 30, 2024Reported Earnings • Feb 14Third quarter 2024 earnings released: EPS: ₹36.85 (vs ₹81.27 in 3Q 2023)Third quarter 2024 results: EPS: ₹36.85 (down from ₹81.27 in 3Q 2023). Revenue: ₹2.36b (down 24% from 3Q 2023). Net income: ₹153.1m (down 55% from 3Q 2023). Profit margin: 6.5% (down from 11% in 3Q 2023). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has fallen by 20% per year but the company’s share price has only fallen by 3% per year, which means it has not declined as severely as earnings.Reported Earnings • Nov 10Second quarter 2024 earnings released: EPS: ₹14.44 (vs ₹55.18 in 2Q 2023)Second quarter 2024 results: EPS: ₹14.44 (down from ₹55.18 in 2Q 2023). Revenue: ₹2.67b (down 8.5% from 2Q 2023). Net income: ₹60.0m (down 74% from 2Q 2023). Profit margin: 2.2% (down from 7.9% in 2Q 2023). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has fallen by 11% per year but the company’s share price has increased by 2% per year, which means it is well ahead of earnings.공시 • Sep 14Bharat Rasayan Limited, Annual General Meeting, Sep 13, 2023Bharat Rasayan Limited, Annual General Meeting, Sep 13, 2023. Location: at hotel golden grand, W-1/10, west patel nagar New Delhi India Agenda: To consider and adopt the audited financial statement of the company for the financial year ended March 31, 2023; to consider and declaration of final dividend for the year ended on March 31, 2023; to consider and appointment of director in place of Shri kamleshwar Prasad Uniyal anf Shri Sat Narain Gupta; and to consider other matter also.Upcoming Dividend • Aug 30Upcoming dividend of ₹1.50 per shareEligible shareholders must have bought the stock before 06 September 2023. Payment date: 13 October 2023. Payout ratio is a comfortable 0.5% and this is well supported by cash flows. The company last paid an ordinary dividend in October 2012. The average dividend yield among industry peers is 0.8%.New Risk • Aug 11New minor risk - Profit margin trendThe company's profit margins are lower than last year and have reduced by more than 30%. Net profit margin: 8.2% Last year net profit margin: 13% This is considered a minor risk. A large drop in profit margin could indicate the company does not have strong competitive advantages or it is yet to establish itself and its core business. Even if it is a well established business, this may make it a much riskier investment than one that has a combination of proven competitive advantages and a stable or growing profit margin. This is currently the only risk that has been identified for the company.Reported Earnings • Aug 11First quarter 2024 earnings released: EPS: ₹17.06 (vs ₹90.63 in 1Q 2023)First quarter 2024 results: EPS: ₹17.06 (down from ₹90.63 in 1Q 2023). Revenue: ₹2.39b (down 27% from 1Q 2023). Net income: ₹70.9m (down 81% from 1Q 2023). Profit margin: 3.0% (down from 12% in 1Q 2023). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has fallen by 5% per year whereas the company’s share price has fallen by 3% per year.Reported Earnings • Jun 01Full year 2023 earnings released: EPS: ₹300 (vs ₹424 in FY 2022)Full year 2023 results: EPS: ₹300 (down from ₹424 in FY 2022). Revenue: ₹12.5b (down 3.6% from FY 2022). Net income: ₹1.25b (down 29% from FY 2022). Profit margin: 9.9% (down from 14% in FY 2022). Over the last 3 years on average, earnings per share has increased by 1% per year but the company’s share price has increased by 13% per year, which means it is tracking significantly ahead of earnings growth.Reported Earnings • Feb 08Third quarter 2023 earnings released: EPS: ₹81.27 (vs ₹110 in 3Q 2022)Third quarter 2023 results: EPS: ₹81.27 (down from ₹110 in 3Q 2022). Revenue: ₹3.15b (down 6.0% from 3Q 2022). Net income: ₹337.7m (down 26% from 3Q 2022). Profit margin: 11% (down from 14% in 3Q 2022). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has increased by 4% per year whereas the company’s share price has increased by 5% per year.공시 • Jan 23Bharat Rasayan Limited to Report Q3, 2023 Results on Feb 07, 2023Bharat Rasayan Limited announced that they will report Q3, 2023 results on Feb 07, 2023Board Change • Nov 16Insufficient new directorsThere is 1 new director who has joined the board in the last 3 years. The company's board is composed of: 1 new director. 3 experienced directors. 6 highly experienced directors. Independent & Non-Executive Director Ankit Aggarwal was the last director to join the board, commencing their role in 2022. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.Reported Earnings • Nov 12Second quarter 2023 earnings released: EPS: ₹55.18 (vs ₹63.70 in 2Q 2022)Second quarter 2023 results: EPS: ₹55.18 (down from ₹63.70 in 2Q 2022). Revenue: ₹2.96b (up 10% from 2Q 2022). Net income: ₹229.3m (down 13% from 2Q 2022). Profit margin: 7.7% (down from 9.8% in 2Q 2022). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 6% per year but the company’s share price has increased by 18% per year, which means it is tracking significantly ahead of earnings growth.공시 • Sep 16Bharat Rasayan Limited Approves Declaration of Final Dividend for the Year Ended March 31, 2022Bharat Rasayan Limited announced that at its AGM held on September 13, 2022, approved the declaration of final dividend of INR 1.50 per equity share of INR 10 each for the year ended March 31, 2022.Upcoming Dividend • Aug 29Upcoming dividend of ₹1.50 per shareEligible shareholders must have bought the stock before 05 September 2022. Payment date: 12 October 2022. Payout ratio is a comfortable 0.4% but the company is not cash flow positive. The company last paid an ordinary dividend in October 2012. The average dividend yield among industry peers is 0.7%.Reported Earnings • Aug 10First quarter 2023 earnings released: EPS: ₹90.63 (vs ₹95.01 in 1Q 2022)First quarter 2023 results: EPS: ₹90.63 (down from ₹95.01 in 1Q 2022). Revenue: ₹3.35b (up 33% from 1Q 2022). Net income: ₹376.6m (down 4.6% from 1Q 2022). Profit margin: 11% (down from 16% in 1Q 2022). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 7% per year but the company’s share price has increased by 35% per year, which means it is tracking significantly ahead of earnings growth.Reported Earnings • May 30Full year 2022 earnings released: EPS: ₹424 (vs ₹386 in FY 2021)Full year 2022 results: EPS: ₹424 (up from ₹386 in FY 2021). Revenue: ₹13.0b (up 19% from FY 2021). Net income: ₹1.76b (up 7.4% from FY 2021). Profit margin: 14% (down from 15% in FY 2021). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 9% per year but the company’s share price has increased by 41% per year, which means it is tracking significantly ahead of earnings growth.Board Change • Apr 27Insufficient new directorsThere is 1 new director who has joined the board in the last 3 years. The company's board is composed of: 1 new director. 4 experienced directors. 5 highly experienced directors. Additional Non-Executive Independent Director Pradeep Aggarwal was the last director to join the board, commencing their role in 2020. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.Board Change • Apr 02Insufficient new directorsThere is 1 new director who has joined the board in the last 3 years. The company's board is composed of: 1 new director. 4 experienced directors. 5 highly experienced directors. Additional Non-Executive Independent Director Pradeep Aggarwal was the last director to join the board, commencing their role in 2020. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.Recent Insider Transactions • Mar 23Executive Chairman & MD recently sold ₹16m worth of stockOn the 16th of March, Sat Gupta sold around 1k shares on-market at roughly ₹12,786 per share. This was the largest sale by an insider in the last 3 months. This was Sat's only on-market trade for the last 12 months.Valuation Update With 7 Day Price Move • Mar 14Investor sentiment improved over the past weekAfter last week's 15% share price gain to ₹13,271, the stock trades at a trailing P/E ratio of 34.8x. Average trailing P/E is 18x in the Chemicals industry in India. Total returns to shareholders of 204% over the past three years.Reported Earnings • Feb 13Third quarter 2022 earnings: Revenues and EPS in line with analyst expectationsThird quarter 2022 results: EPS: ₹110 (up from ₹82.66 in 3Q 2021). Revenue: ₹3.35b (up 51% from 3Q 2021). Net income: ₹458.8m (up 31% from 3Q 2021). Profit margin: 14% (down from 16% in 3Q 2021). The decrease in margin was driven by higher expenses. Revenue was in line with analyst estimates. Over the last 3 years on average, earnings per share has increased by 9% per year but the company’s share price has increased by 51% per year, which means it is tracking significantly ahead of earnings growth.Valuation Update With 7 Day Price Move • Dec 30Investor sentiment improved over the past weekAfter last week's 15% share price gain to ₹11,828, the stock trades at a trailing P/E ratio of 32.5x. Average trailing P/E is 19x in the Chemicals industry in India. Total returns to shareholders of 125% over the past three years.Reported Earnings • Nov 15Second quarter 2022 earnings released: EPS ₹63.70 (vs ₹83.01 in 2Q 2021)The company reported a poor second quarter result with weaker earnings, revenues and profit margins. Second quarter 2022 results: Revenue: ₹2.69b (down 16% from 2Q 2021). Net income: ₹264.7m (down 25% from 2Q 2021). Profit margin: 9.8% (down from 11% in 2Q 2021). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has increased by 10% per year but the company’s share price has increased by 21% per year, which means it is tracking significantly ahead of earnings growth.Upcoming Dividend • Aug 30Inaugural dividend of ₹1.50 per shareEligible shareholders must have bought the stock before 06 September 2021. Payment date: 14 October 2021. The company last paid an ordinary dividend in August 2021. The average dividend yield among industry peers is 0.7%.Reported Earnings • Aug 12First quarter 2022 earnings released: EPS ₹95.01 (vs ₹110 in 1Q 2021)The company reported a poor first quarter result with weaker earnings, revenues and profit margins. First quarter 2022 results: Revenue: ₹2.55b (down 9.5% from 1Q 2021). Net income: ₹394.8m (down 16% from 1Q 2021). Profit margin: 16% (down from 17% in 1Q 2021). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has increased by 13% per year but the company’s share price has increased by 24% per year, which means it is tracking significantly ahead of earnings growth.Reported Earnings • Jul 02Full year 2021 earnings released: EPS ₹386 (vs ₹371 in FY 2020)The company reported a decent full year result with improved earnings and profit margins, although revenues were weaker. Full year 2021 results: Revenue: ₹11.0b (down 9.5% from FY 2020). Net income: ₹1.64b (up 4.0% from FY 2020). Profit margin: 15% (up from 13% in FY 2020). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has increased by 16% per year but the company’s share price has increased by 31% per year, which means it is tracking significantly ahead of earnings growth.Valuation Update With 7 Day Price Move • Apr 29Investor sentiment improved over the past weekAfter last week's 32% share price gain to ₹12,797, the stock trades at a trailing P/E ratio of 29.8x. Average trailing P/E is 18x in the Chemicals industry in India. Total returns to shareholders of 82% over the past three years.Reported Earnings • Feb 15Third quarter 2021 earnings released: EPS ₹82.66 (vs ₹59.01 in 3Q 2020)The company reported a decent third quarter result with improved earnings and profit margins, although revenues were flat. Third quarter 2021 results: Revenue: ₹2.22b (flat on 3Q 2020). Net income: ₹351.2m (up 40% from 3Q 2020). Profit margin: 16% (up from 11% in 3Q 2020). Over the last 3 years on average, earnings per share has increased by 19% per year but the company’s share price has increased by 29% per year, which means it is tracking significantly ahead of earnings growth.공시 • Jan 29Bharat Rasayan Limited to Report Q3, 2021 Results on Feb 10, 2021Bharat Rasayan Limited announced that they will report Q3, 2021 results on Feb 10, 2021Is New 90 Day High Low • Jan 08New 90-day high: ₹10,205The company is up 15% from its price of ₹8,872 on 09 October 2020. The Indian market is up 20% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 24% over the same period.Is New 90 Day High Low • Nov 02New 90-day low: ₹8,543The company is down 10.0% from its price of ₹9,461 on 04 August 2020. The Indian market is up 7.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 15% over the same period.Is New 90 Day High Low • Oct 09New 90-day low: ₹8,872The company is down 8.0% from its price of ₹9,656 on 10 July 2020. The Indian market is up 10.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 15% over the same period.공시 • Sep 19Bharat Rasayan Limited to Report Q1, 2021 Results on Aug 13, 2020Bharat Rasayan Limited announced that they will report Q1, 2021 results on Aug 13, 2020공시 • Jun 21Bharat Rasayan Limited to Report Q4, 2020 Results on Jun 26, 2020Bharat Rasayan Limited announced that they will report Q4, 2020 results on Jun 26, 2020주주 수익률590021IN ChemicalsIN 시장7D-4.1%-1.7%-2.8%1Y-42.1%-2.6%-1.2%전체 주주 수익률 보기수익률 대 산업: 590021은 지난 1년 동안 -2.6%의 수익을 기록한 Indian Chemicals 산업보다 저조한 성과를 냈습니다.수익률 대 시장: 590021은 지난 1년 동안 -1.2%를 기록한 Indian 시장보다 저조한 성과를 냈습니다.주가 변동성Is 590021's price volatile compared to industry and market?590021 volatility590021 Average Weekly Movement6.9%Chemicals Industry Average Movement7.1%Market Average Movement7.1%10% most volatile stocks in IN Market10.1%10% least volatile stocks in IN Market4.7%안정적인 주가: 590021는 지난 3개월 동안 Indian 시장에 비해 주가 변동성이 크지 않았습니다.시간에 따른 변동성: 590021의 주간 변동성(7%)은 지난 1년 동안 안정적이었습니다.회사 소개설립직원 수CEO웹사이트1989861Sat Guptawww.bharatgroup.co.in바라트 라사얀은 인도에서 기술 등급 농약과 중간체를 제조 및 판매하는 회사입니다. 이 회사는 살충제, 제초제, 살균제 및 중간체를 제공합니다. 또한 다국적 농약 회사 및 기타 상인을 통해 제품을 수출합니다.더 보기Bharat Rasayan Limited 기초 지표 요약Bharat Rasayan의 순이익과 매출은 시가총액과 어떻게 비교됩니까?590021 기초 통계시가총액₹22.94b순이익 (TTM)₹1.33b매출 (TTM)₹12.40b17.3x주가수익비율(P/E)1.8x주가매출비율(P/S)590021는 고평가되어 있습니까?공정 가치 및 평가 분석 보기순이익 및 매출최근 실적 보고서(TTM)의 주요 수익성 지표590021 손익계산서 (TTM)매출₹12.40b매출원가₹8.17b총이익₹4.23b기타 비용₹2.90b순이익₹1.33b최근 보고된 실적Dec 31, 2025다음 실적 발표일May 26, 2026주당순이익(EPS)79.84총이익률34.11%순이익률10.70%부채/자본 비율7.6%590021의 장기 실적은 어땠습니까?과거 실적 및 비교 보기배당0.03%현재 배당 수익률0.4423%배당 성향View Valuation기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2026/05/16 19:21종가2026/05/15 00:00수익2025/12/31연간 수익2025/03/31데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델에 대한 자세한 내용은 당사의 Github 페이지에서 확인하실 수 있습니다. 또한 보고서 활용 방법에 대한 가이드와 YouTube 튜토리얼도 제공합니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스Bharat Rasayan Limited는 1명의 분석가가 다루고 있습니다. 이 중 0명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.분석가기관Kameswari V. S. ChavaliFirstCall Research
공시 • May 09Bharat Rasayan Limited to Report Q4, 2026 Results on May 26, 2026Bharat Rasayan Limited announced that they will report Q4, 2026 results on May 26, 2026
Valuation Update With 7 Day Price Move • Apr 13Investor sentiment improves as stock rises 18%After last week's 18% share price gain to ₹1,573, the stock trades at a trailing P/E ratio of 19.7x. Average trailing P/E is 21x in the Chemicals industry in India. Total loss to shareholders of 34% over the past three years.
Reported Earnings • Feb 14Third quarter 2026 earnings released: EPS: ₹24.08 (vs ₹24.39 in 3Q 2025)Third quarter 2026 results: EPS: ₹24.08 (down from ₹24.39 in 3Q 2025). Revenue: ₹2.80b (up 9.2% from 3Q 2025). Net income: ₹400.3m (down 1.2% from 3Q 2025). Profit margin: 14% (down from 16% in 3Q 2025). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 10% per year but the company’s share price has fallen by 9% per year, which means it is significantly lagging earnings.
Valuation Update With 7 Day Price Move • Feb 03Investor sentiment improves as stock rises 16%After last week's 16% share price gain to ₹1,939, the stock trades at a trailing P/E ratio of 24.2x. Average trailing P/E is 22x in the Chemicals industry in India. Total loss to shareholders of 14% over the past three years.
공시 • Jan 30Bharat Rasayan Limited to Report Q3, 2026 Results on Feb 12, 2026Bharat Rasayan Limited announced that they will report Q3, 2026 results on Feb 12, 2026
New Risk • Jan 20New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 7.8% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 4.6% per year over the past 5 years. Minor Risk Share price has been volatile over the past 3 months (7.8% average weekly change).
공시 • May 09Bharat Rasayan Limited to Report Q4, 2026 Results on May 26, 2026Bharat Rasayan Limited announced that they will report Q4, 2026 results on May 26, 2026
Valuation Update With 7 Day Price Move • Apr 13Investor sentiment improves as stock rises 18%After last week's 18% share price gain to ₹1,573, the stock trades at a trailing P/E ratio of 19.7x. Average trailing P/E is 21x in the Chemicals industry in India. Total loss to shareholders of 34% over the past three years.
Reported Earnings • Feb 14Third quarter 2026 earnings released: EPS: ₹24.08 (vs ₹24.39 in 3Q 2025)Third quarter 2026 results: EPS: ₹24.08 (down from ₹24.39 in 3Q 2025). Revenue: ₹2.80b (up 9.2% from 3Q 2025). Net income: ₹400.3m (down 1.2% from 3Q 2025). Profit margin: 14% (down from 16% in 3Q 2025). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 10% per year but the company’s share price has fallen by 9% per year, which means it is significantly lagging earnings.
Valuation Update With 7 Day Price Move • Feb 03Investor sentiment improves as stock rises 16%After last week's 16% share price gain to ₹1,939, the stock trades at a trailing P/E ratio of 24.2x. Average trailing P/E is 22x in the Chemicals industry in India. Total loss to shareholders of 14% over the past three years.
공시 • Jan 30Bharat Rasayan Limited to Report Q3, 2026 Results on Feb 12, 2026Bharat Rasayan Limited announced that they will report Q3, 2026 results on Feb 12, 2026
New Risk • Jan 20New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 7.8% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 4.6% per year over the past 5 years. Minor Risk Share price has been volatile over the past 3 months (7.8% average weekly change).
공시 • Jan 20Bharat Rasayan Limited Announces Change in Designation of Rajender Prasad Gupta from Executive Director to Non-Executive, Non-Independent Director, Effective January 19, 2026Bharat Rasayan Limited announced that the Board of Directors of the Company, at its meeting held on January 19, 2026, has approved the letter dated January 19, 2026 received from Shri Rajender Prasad Gupta (DIN:00048888) regarding the change in his designation from Executive Director to Non-Executive, Non-Independent Director, with effect from January 19, 2026. The change in designation is due to other occupancies of Sh. Rajender Prasad Gupta, for which he step back from day-to-day executive responsibilities. He will continue to serve on the Board in a Non-Executive Director capacity.
Valuation Update With 7 Day Price Move • Jan 20Investor sentiment deteriorates as stock falls 23%After last week's 23% share price decline to ₹1,684, the stock trades at a trailing P/E ratio of 21.1x. Average trailing P/E is 23x in the Chemicals industry in India. Total loss to shareholders of 29% over the past three years.
Valuation Update With 7 Day Price Move • Oct 23Investor sentiment improves as stock rises 23%After last week's 23% share price gain to ₹11,640, the stock trades at a trailing P/E ratio of 35.1x. Average trailing P/E is 26x in the Chemicals industry in India. Total returns to shareholders of 3.4% over the past three years.
Upcoming Dividend • Sep 05Upcoming dividend of ₹1.50 per shareEligible shareholders must have bought the stock before 12 September 2025. Payment date: 19 October 2025. Payout ratio is a comfortable 0.4% and this is well supported by cash flows. The company last paid an ordinary dividend in May 2015. The average dividend yield among industry peers is 0.7%.
Declared Dividend • Aug 15Dividend of ₹1.50 announcedDividend of ₹1.50 is the same as last year. Ex-date: 12th September 2025 Payment date: 19th October 2025 Dividend yield will be 0.01%, which is lower than the industry average of 0.8%. Payout Ratios Payout ratio: 0.4423%. Cash payout ratio: 0.4572%.
공시 • Aug 14Bharat Rasayan Limited announces Annual dividend, payable on October 19, 2025Bharat Rasayan Limited announced Annual dividend of INR 1.5000 per share payable on October 19, 2025, ex-date on September 12, 2025 and record date on September 12, 2025.
Reported Earnings • Aug 14First quarter 2026 earnings released: EPS: ₹95.45 (vs ₹104 in 1Q 2025)First quarter 2026 results: EPS: ₹95.45 (down from ₹104 in 1Q 2025). Revenue: ₹3.77b (up 34% from 1Q 2025). Net income: ₹396.6m (down 8.0% from 1Q 2025). Profit margin: 11% (down from 15% in 1Q 2025). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has fallen by 1% per year whereas the company’s share price has fallen by 3% per year.
공시 • Aug 13Bharat Rasayan Limited, Annual General Meeting, Sep 19, 2025Bharat Rasayan Limited, Annual General Meeting, Sep 19, 2025.
Valuation Update With 7 Day Price Move • Jun 17Investor sentiment improves as stock rises 16%After last week's 16% share price gain to ₹10,419, the stock trades at a trailing P/E ratio of 30.7x. Average trailing P/E is 29x in the Chemicals industry in India. Total loss to shareholders of 1.8% over the past three years.
Reported Earnings • May 29Full year 2025 earnings released: EPS: ₹678 (vs ₹230 in FY 2024)Full year 2025 results: EPS: ₹678 (up from ₹230 in FY 2024). Revenue: ₹24.0b (up 130% from FY 2024). Net income: ₹2.82b (up 195% from FY 2024). Profit margin: 12% (up from 9.1% in FY 2024). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 7% per year but the company’s share price has fallen by 10% per year, which means it is significantly lagging earnings.
Reported Earnings • Feb 15Third quarter 2025 earnings released: EPS: ₹97.54 (vs ₹36.85 in 3Q 2024)Third quarter 2025 results: EPS: ₹97.54 (up from ₹36.85 in 3Q 2024). Revenue: ₹2.64b (up 13% from 3Q 2024). Net income: ₹405.3m (up 165% from 3Q 2024). Profit margin: 15% (up from 6.6% in 3Q 2024). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 9% per year whereas the company’s share price has fallen by 7% per year.
공시 • Jan 21Bharat Rasayan Limited to Report Q3, 2025 Results on Feb 13, 2025Bharat Rasayan Limited announced that they will report Q3, 2025 results on Feb 13, 2025
공시 • Oct 22Bharat Rasayan Limited to Report Q2, 2025 Results on Nov 12, 2024Bharat Rasayan Limited announced that they will report Q2, 2025 results on Nov 12, 2024
Upcoming Dividend • Sep 05Upcoming dividend of ₹1.50 per shareEligible shareholders must have bought the stock before 12 September 2024. Payment date: 19 October 2024. Payout ratio is a comfortable 0.7% and this is well supported by cash flows. The company last paid an ordinary dividend in May 2014. The average dividend yield among industry peers is 0.6%.
Declared Dividend • Aug 10Dividend of ₹1.50 announcedDividend of ₹1.50 is the same as last year. Ex-date: 12th September 2024 Payment date: 19th October 2024 Dividend yield will be 0.01%, which is lower than the industry average of 0.8%. Payout Ratios Payout ratio: 0.6526%. Cash payout ratio: 4%.
공시 • Aug 09Bharat Rasayan Limited, Annual General Meeting, Sep 19, 2024Bharat Rasayan Limited, Annual General Meeting, Sep 19, 2024.
New Risk • Aug 09New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Indian stocks, typically moving 10% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (10% average weekly change). Earnings have declined by 7.9% per year over the past 5 years.
Reported Earnings • Aug 09First quarter 2025 earnings released: EPS: ₹104 (vs ₹17.06 in 1Q 2024)First quarter 2025 results: EPS: ₹104 (up from ₹17.06 in 1Q 2024). Revenue: ₹2.88b (up 20% from 1Q 2024). Net income: ₹431.2m (up ₹360.3m from 1Q 2024). Profit margin: 15% (up from 3.0% in 1Q 2024). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 21% per year but the company’s share price has only fallen by 1% per year, which means it has not declined as severely as earnings.
공시 • Aug 09Bharat Rasayan Limited Announces Cessation of Smt. Sujata Agarwal as an Independent & Non Executive Woman Director, effective August 31, 2024Bharat Rasayan Limited informed that the existing tenure of Smt. Sujata Agarwal as an Independent & Non Executive Woman Director of the Company is going to be completed on August 31, 2024. Company further confirmed that there is no other material reason for his cessation other than those provided above.
New Risk • Jun 13New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 8.5% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 6.6% per year over the past 5 years. Minor Risk Share price has been volatile over the past 3 months (8.5% average weekly change).
Reported Earnings • Jun 04Full year 2024 earnings released: EPS: ₹230 (vs ₹300 in FY 2023)Full year 2024 results: EPS: ₹230 (down from ₹300 in FY 2023). Revenue: ₹10.7b (down 14% from FY 2023). Net income: ₹955.1m (down 23% from FY 2023). Profit margin: 9.0% (down from 10% in FY 2023). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has fallen by 24% per year but the company’s share price has only fallen by 9% per year, which means it has not declined as severely as earnings.
공시 • May 31Bharat Rasayan Limited Recommends Final Dividend for the Financial Year Ended March 31, 2024The board of directors of Bharat Rasayan Limited at its meeting held on May 30, 2024, recommended a final dividend @15%, i.e. INR 1.50 per share on the fully paid-up equity shares on INR 10 each for the financial year ended March 31, 2024. However, the final dividend of INR 1.50 per share recommended would be payable after the approval of the said final dividend by the shareholders of the Company in their forthcoming Annual General Meeting.
Valuation Update With 7 Day Price Move • May 31Investor sentiment improves as stock rises 15%After last week's 15% share price gain to ₹10,699, the stock trades at a trailing P/E ratio of 75.8x. Average trailing P/E is 29x in the Chemicals industry in India. Total loss to shareholders of 18% over the past three years.
공시 • May 05Bharat Rasayan Limited to Report Q4, 2024 Results on May 30, 2024Bharat Rasayan Limited announced that they will report Q4, 2024 results on May 30, 2024
Reported Earnings • Feb 14Third quarter 2024 earnings released: EPS: ₹36.85 (vs ₹81.27 in 3Q 2023)Third quarter 2024 results: EPS: ₹36.85 (down from ₹81.27 in 3Q 2023). Revenue: ₹2.36b (down 24% from 3Q 2023). Net income: ₹153.1m (down 55% from 3Q 2023). Profit margin: 6.5% (down from 11% in 3Q 2023). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has fallen by 20% per year but the company’s share price has only fallen by 3% per year, which means it has not declined as severely as earnings.
Reported Earnings • Nov 10Second quarter 2024 earnings released: EPS: ₹14.44 (vs ₹55.18 in 2Q 2023)Second quarter 2024 results: EPS: ₹14.44 (down from ₹55.18 in 2Q 2023). Revenue: ₹2.67b (down 8.5% from 2Q 2023). Net income: ₹60.0m (down 74% from 2Q 2023). Profit margin: 2.2% (down from 7.9% in 2Q 2023). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has fallen by 11% per year but the company’s share price has increased by 2% per year, which means it is well ahead of earnings.
공시 • Sep 14Bharat Rasayan Limited, Annual General Meeting, Sep 13, 2023Bharat Rasayan Limited, Annual General Meeting, Sep 13, 2023. Location: at hotel golden grand, W-1/10, west patel nagar New Delhi India Agenda: To consider and adopt the audited financial statement of the company for the financial year ended March 31, 2023; to consider and declaration of final dividend for the year ended on March 31, 2023; to consider and appointment of director in place of Shri kamleshwar Prasad Uniyal anf Shri Sat Narain Gupta; and to consider other matter also.
Upcoming Dividend • Aug 30Upcoming dividend of ₹1.50 per shareEligible shareholders must have bought the stock before 06 September 2023. Payment date: 13 October 2023. Payout ratio is a comfortable 0.5% and this is well supported by cash flows. The company last paid an ordinary dividend in October 2012. The average dividend yield among industry peers is 0.8%.
New Risk • Aug 11New minor risk - Profit margin trendThe company's profit margins are lower than last year and have reduced by more than 30%. Net profit margin: 8.2% Last year net profit margin: 13% This is considered a minor risk. A large drop in profit margin could indicate the company does not have strong competitive advantages or it is yet to establish itself and its core business. Even if it is a well established business, this may make it a much riskier investment than one that has a combination of proven competitive advantages and a stable or growing profit margin. This is currently the only risk that has been identified for the company.
Reported Earnings • Aug 11First quarter 2024 earnings released: EPS: ₹17.06 (vs ₹90.63 in 1Q 2023)First quarter 2024 results: EPS: ₹17.06 (down from ₹90.63 in 1Q 2023). Revenue: ₹2.39b (down 27% from 1Q 2023). Net income: ₹70.9m (down 81% from 1Q 2023). Profit margin: 3.0% (down from 12% in 1Q 2023). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has fallen by 5% per year whereas the company’s share price has fallen by 3% per year.
Reported Earnings • Jun 01Full year 2023 earnings released: EPS: ₹300 (vs ₹424 in FY 2022)Full year 2023 results: EPS: ₹300 (down from ₹424 in FY 2022). Revenue: ₹12.5b (down 3.6% from FY 2022). Net income: ₹1.25b (down 29% from FY 2022). Profit margin: 9.9% (down from 14% in FY 2022). Over the last 3 years on average, earnings per share has increased by 1% per year but the company’s share price has increased by 13% per year, which means it is tracking significantly ahead of earnings growth.
Reported Earnings • Feb 08Third quarter 2023 earnings released: EPS: ₹81.27 (vs ₹110 in 3Q 2022)Third quarter 2023 results: EPS: ₹81.27 (down from ₹110 in 3Q 2022). Revenue: ₹3.15b (down 6.0% from 3Q 2022). Net income: ₹337.7m (down 26% from 3Q 2022). Profit margin: 11% (down from 14% in 3Q 2022). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has increased by 4% per year whereas the company’s share price has increased by 5% per year.
공시 • Jan 23Bharat Rasayan Limited to Report Q3, 2023 Results on Feb 07, 2023Bharat Rasayan Limited announced that they will report Q3, 2023 results on Feb 07, 2023
Board Change • Nov 16Insufficient new directorsThere is 1 new director who has joined the board in the last 3 years. The company's board is composed of: 1 new director. 3 experienced directors. 6 highly experienced directors. Independent & Non-Executive Director Ankit Aggarwal was the last director to join the board, commencing their role in 2022. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.
Reported Earnings • Nov 12Second quarter 2023 earnings released: EPS: ₹55.18 (vs ₹63.70 in 2Q 2022)Second quarter 2023 results: EPS: ₹55.18 (down from ₹63.70 in 2Q 2022). Revenue: ₹2.96b (up 10% from 2Q 2022). Net income: ₹229.3m (down 13% from 2Q 2022). Profit margin: 7.7% (down from 9.8% in 2Q 2022). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 6% per year but the company’s share price has increased by 18% per year, which means it is tracking significantly ahead of earnings growth.
공시 • Sep 16Bharat Rasayan Limited Approves Declaration of Final Dividend for the Year Ended March 31, 2022Bharat Rasayan Limited announced that at its AGM held on September 13, 2022, approved the declaration of final dividend of INR 1.50 per equity share of INR 10 each for the year ended March 31, 2022.
Upcoming Dividend • Aug 29Upcoming dividend of ₹1.50 per shareEligible shareholders must have bought the stock before 05 September 2022. Payment date: 12 October 2022. Payout ratio is a comfortable 0.4% but the company is not cash flow positive. The company last paid an ordinary dividend in October 2012. The average dividend yield among industry peers is 0.7%.
Reported Earnings • Aug 10First quarter 2023 earnings released: EPS: ₹90.63 (vs ₹95.01 in 1Q 2022)First quarter 2023 results: EPS: ₹90.63 (down from ₹95.01 in 1Q 2022). Revenue: ₹3.35b (up 33% from 1Q 2022). Net income: ₹376.6m (down 4.6% from 1Q 2022). Profit margin: 11% (down from 16% in 1Q 2022). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 7% per year but the company’s share price has increased by 35% per year, which means it is tracking significantly ahead of earnings growth.
Reported Earnings • May 30Full year 2022 earnings released: EPS: ₹424 (vs ₹386 in FY 2021)Full year 2022 results: EPS: ₹424 (up from ₹386 in FY 2021). Revenue: ₹13.0b (up 19% from FY 2021). Net income: ₹1.76b (up 7.4% from FY 2021). Profit margin: 14% (down from 15% in FY 2021). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 9% per year but the company’s share price has increased by 41% per year, which means it is tracking significantly ahead of earnings growth.
Board Change • Apr 27Insufficient new directorsThere is 1 new director who has joined the board in the last 3 years. The company's board is composed of: 1 new director. 4 experienced directors. 5 highly experienced directors. Additional Non-Executive Independent Director Pradeep Aggarwal was the last director to join the board, commencing their role in 2020. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.
Board Change • Apr 02Insufficient new directorsThere is 1 new director who has joined the board in the last 3 years. The company's board is composed of: 1 new director. 4 experienced directors. 5 highly experienced directors. Additional Non-Executive Independent Director Pradeep Aggarwal was the last director to join the board, commencing their role in 2020. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.
Recent Insider Transactions • Mar 23Executive Chairman & MD recently sold ₹16m worth of stockOn the 16th of March, Sat Gupta sold around 1k shares on-market at roughly ₹12,786 per share. This was the largest sale by an insider in the last 3 months. This was Sat's only on-market trade for the last 12 months.
Valuation Update With 7 Day Price Move • Mar 14Investor sentiment improved over the past weekAfter last week's 15% share price gain to ₹13,271, the stock trades at a trailing P/E ratio of 34.8x. Average trailing P/E is 18x in the Chemicals industry in India. Total returns to shareholders of 204% over the past three years.
Reported Earnings • Feb 13Third quarter 2022 earnings: Revenues and EPS in line with analyst expectationsThird quarter 2022 results: EPS: ₹110 (up from ₹82.66 in 3Q 2021). Revenue: ₹3.35b (up 51% from 3Q 2021). Net income: ₹458.8m (up 31% from 3Q 2021). Profit margin: 14% (down from 16% in 3Q 2021). The decrease in margin was driven by higher expenses. Revenue was in line with analyst estimates. Over the last 3 years on average, earnings per share has increased by 9% per year but the company’s share price has increased by 51% per year, which means it is tracking significantly ahead of earnings growth.
Valuation Update With 7 Day Price Move • Dec 30Investor sentiment improved over the past weekAfter last week's 15% share price gain to ₹11,828, the stock trades at a trailing P/E ratio of 32.5x. Average trailing P/E is 19x in the Chemicals industry in India. Total returns to shareholders of 125% over the past three years.
Reported Earnings • Nov 15Second quarter 2022 earnings released: EPS ₹63.70 (vs ₹83.01 in 2Q 2021)The company reported a poor second quarter result with weaker earnings, revenues and profit margins. Second quarter 2022 results: Revenue: ₹2.69b (down 16% from 2Q 2021). Net income: ₹264.7m (down 25% from 2Q 2021). Profit margin: 9.8% (down from 11% in 2Q 2021). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has increased by 10% per year but the company’s share price has increased by 21% per year, which means it is tracking significantly ahead of earnings growth.
Upcoming Dividend • Aug 30Inaugural dividend of ₹1.50 per shareEligible shareholders must have bought the stock before 06 September 2021. Payment date: 14 October 2021. The company last paid an ordinary dividend in August 2021. The average dividend yield among industry peers is 0.7%.
Reported Earnings • Aug 12First quarter 2022 earnings released: EPS ₹95.01 (vs ₹110 in 1Q 2021)The company reported a poor first quarter result with weaker earnings, revenues and profit margins. First quarter 2022 results: Revenue: ₹2.55b (down 9.5% from 1Q 2021). Net income: ₹394.8m (down 16% from 1Q 2021). Profit margin: 16% (down from 17% in 1Q 2021). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has increased by 13% per year but the company’s share price has increased by 24% per year, which means it is tracking significantly ahead of earnings growth.
Reported Earnings • Jul 02Full year 2021 earnings released: EPS ₹386 (vs ₹371 in FY 2020)The company reported a decent full year result with improved earnings and profit margins, although revenues were weaker. Full year 2021 results: Revenue: ₹11.0b (down 9.5% from FY 2020). Net income: ₹1.64b (up 4.0% from FY 2020). Profit margin: 15% (up from 13% in FY 2020). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has increased by 16% per year but the company’s share price has increased by 31% per year, which means it is tracking significantly ahead of earnings growth.
Valuation Update With 7 Day Price Move • Apr 29Investor sentiment improved over the past weekAfter last week's 32% share price gain to ₹12,797, the stock trades at a trailing P/E ratio of 29.8x. Average trailing P/E is 18x in the Chemicals industry in India. Total returns to shareholders of 82% over the past three years.
Reported Earnings • Feb 15Third quarter 2021 earnings released: EPS ₹82.66 (vs ₹59.01 in 3Q 2020)The company reported a decent third quarter result with improved earnings and profit margins, although revenues were flat. Third quarter 2021 results: Revenue: ₹2.22b (flat on 3Q 2020). Net income: ₹351.2m (up 40% from 3Q 2020). Profit margin: 16% (up from 11% in 3Q 2020). Over the last 3 years on average, earnings per share has increased by 19% per year but the company’s share price has increased by 29% per year, which means it is tracking significantly ahead of earnings growth.
공시 • Jan 29Bharat Rasayan Limited to Report Q3, 2021 Results on Feb 10, 2021Bharat Rasayan Limited announced that they will report Q3, 2021 results on Feb 10, 2021
Is New 90 Day High Low • Jan 08New 90-day high: ₹10,205The company is up 15% from its price of ₹8,872 on 09 October 2020. The Indian market is up 20% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 24% over the same period.
Is New 90 Day High Low • Nov 02New 90-day low: ₹8,543The company is down 10.0% from its price of ₹9,461 on 04 August 2020. The Indian market is up 7.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 15% over the same period.
Is New 90 Day High Low • Oct 09New 90-day low: ₹8,872The company is down 8.0% from its price of ₹9,656 on 10 July 2020. The Indian market is up 10.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 15% over the same period.
공시 • Sep 19Bharat Rasayan Limited to Report Q1, 2021 Results on Aug 13, 2020Bharat Rasayan Limited announced that they will report Q1, 2021 results on Aug 13, 2020
공시 • Jun 21Bharat Rasayan Limited to Report Q4, 2020 Results on Jun 26, 2020Bharat Rasayan Limited announced that they will report Q4, 2020 results on Jun 26, 2020
